Annual Net Income
-$28.96 M
-$9.52 M-48.94%
31 December 2023
Summary:
AIM ImmunoTech annual net profit is currently -$28.96 million, with the most recent change of -$9.52 million (-48.94%) on 31 December 2023. During the last 3 years, it has fallen by -$14.56 million (-101.12%). AIM annual net income is now -1509.00% below its all-time high of -$1.80 million, reached on 31 December 1995.AIM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$3.70 M
-$1.86 M-101.53%
30 September 2024
Summary:
AIM ImmunoTech quarterly net profit is currently -$3.70 million, with the most recent change of -$1.86 million (-101.53%) on 30 September 2024. Over the past year, it has increased by +$4.12 million (+52.66%). AIM quarterly net income is now -189.87% below its all-time high of $4.12 million, reached on 31 December 2004.AIM Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$23.93 M
+$4.12 M+14.68%
30 September 2024
Summary:
AIM ImmunoTech TTM net profit is currently -$23.93 million, with the most recent change of +$4.12 million (+14.68%) on 30 September 2024. Over the past year, it has dropped by -$3.15 million (-15.18%). AIM TTM net income is now -4685.80% below its all-time high of -$500.00 thousand, reached on 31 March 1995.AIM TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -48.9% | +52.7% | -15.2% |
| 3 y3 years | -101.1% | +3.3% | -39.0% |
| 5 y5 years | -194.7% | -25.5% | -140.0% |
AIM Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -101.1% | at low | -101.5% | +70.6% | -39.0% | +23.1% |
| 5 y | 5 years | -208.0% | at low | -248.1% | +70.6% | -154.2% | +23.1% |
| alltime | all time | -1509.0% | at low | -189.9% | +70.6% | -4685.8% | +23.1% |
AIM ImmunoTech Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.70 M(+101.5%) | -$23.93 M(-14.7%) |
| June 2024 | - | -$1.84 M(-68.4%) | -$28.05 M(-9.9%) |
| Mar 2024 | - | -$5.82 M(-53.7%) | -$31.12 M(+7.4%) |
| Dec 2023 | -$28.96 M(+48.9%) | -$12.58 M(+60.9%) | -$28.96 M(+39.4%) |
| Sept 2023 | - | -$7.82 M(+59.2%) | -$20.77 M(+7.4%) |
| June 2023 | - | -$4.91 M(+34.1%) | -$19.34 M(+0.3%) |
| Mar 2023 | - | -$3.66 M(-16.6%) | -$19.29 M(-0.8%) |
| Dec 2022 | -$19.45 M(+1.7%) | -$4.39 M(-31.3%) | -$19.45 M(-7.0%) |
| Sept 2022 | - | -$6.38 M(+31.6%) | -$20.90 M(+14.0%) |
| June 2022 | - | -$4.85 M(+27.0%) | -$18.34 M(-5.3%) |
| Mar 2022 | - | -$3.82 M(-34.7%) | -$19.37 M(+1.3%) |
| Dec 2021 | -$19.13 M(+32.8%) | -$5.85 M(+52.8%) | -$19.13 M(+11.1%) |
| Sept 2021 | - | -$3.83 M(-34.9%) | -$17.21 M(+3.1%) |
| June 2021 | - | -$5.88 M(+64.2%) | -$16.70 M(+17.7%) |
| Mar 2021 | - | -$3.58 M(-9.0%) | -$14.19 M(-1.6%) |
| Dec 2020 | -$14.40 M(+53.1%) | -$3.93 M(+19.0%) | -$14.42 M(+24.9%) |
| Sept 2020 | - | -$3.31 M(-1.9%) | -$11.55 M(+3.2%) |
| June 2020 | - | -$3.37 M(-11.5%) | -$11.19 M(+13.5%) |
| Mar 2020 | - | -$3.81 M(+258.2%) | -$9.86 M(+4.7%) |
| Dec 2019 | -$9.40 M(-4.3%) | -$1.06 M(-63.9%) | -$9.41 M(-5.6%) |
| Sept 2019 | - | -$2.95 M(+44.8%) | -$9.97 M(-1.3%) |
| June 2019 | - | -$2.04 M(-39.5%) | -$10.10 M(-3.6%) |
| Mar 2019 | - | -$3.37 M(+107.6%) | -$10.48 M(+6.6%) |
| Dec 2018 | -$9.83 M(+19.0%) | -$1.62 M(-47.3%) | -$9.83 M(-3.6%) |
| Sept 2018 | - | -$3.08 M(+27.5%) | -$10.20 M(+21.8%) |
| June 2018 | - | -$2.42 M(-11.0%) | -$8.37 M(+2.7%) |
| Mar 2018 | - | -$2.71 M(+36.1%) | -$8.15 M(-1.3%) |
| Dec 2017 | -$8.26 M(+10.1%) | -$1.99 M(+59.2%) | -$8.26 M(+11.0%) |
| Sept 2017 | - | -$1.25 M(-42.9%) | -$7.44 M(-17.8%) |
| June 2017 | - | -$2.19 M(-22.3%) | -$9.05 M(+10.9%) |
| Mar 2017 | - | -$2.82 M(+140.5%) | -$8.16 M(+8.8%) |
| Dec 2016 | -$7.50 M(-50.7%) | -$1.17 M(-59.0%) | -$7.50 M(-20.7%) |
| Sept 2016 | - | -$2.86 M(+119.6%) | -$9.47 M(-9.0%) |
| June 2016 | - | -$1.30 M(-39.8%) | -$10.41 M(-25.4%) |
| Mar 2016 | - | -$2.16 M(-31.0%) | -$13.95 M(-8.4%) |
| Dec 2015 | -$15.23 M(-12.7%) | -$3.14 M(-17.5%) | -$15.23 M(-8.0%) |
| Sept 2015 | - | -$3.80 M(-21.5%) | -$16.55 M(-2.4%) |
| June 2015 | - | -$4.84 M(+40.6%) | -$16.95 M(-0.7%) |
| Mar 2015 | - | -$3.44 M(-22.7%) | -$17.06 M(-2.2%) |
| Dec 2014 | -$17.45 M(+7.6%) | -$4.46 M(+6.0%) | -$17.45 M(+7.8%) |
| Sept 2014 | - | -$4.20 M(-15.2%) | -$16.19 M(-5.5%) |
| June 2014 | - | -$4.96 M(+29.2%) | -$17.12 M(+4.1%) |
| Mar 2014 | - | -$3.84 M(+20.1%) | -$16.45 M(+1.4%) |
| Dec 2013 | -$16.23 M(-6.5%) | -$3.19 M(-37.8%) | -$16.23 M(-12.2%) |
| Sept 2013 | - | -$5.14 M(+19.9%) | -$18.49 M(-7.3%) |
| June 2013 | - | -$4.28 M(+18.6%) | -$19.94 M(+6.9%) |
| Mar 2013 | - | -$3.61 M(-33.9%) | -$18.66 M(+7.5%) |
| Dec 2012 | -$17.35 M(+92.5%) | -$5.46 M(-17.1%) | -$17.35 M(+15.6%) |
| Sept 2012 | - | -$6.59 M(+119.6%) | -$15.01 M(+34.5%) |
| June 2012 | - | -$3.00 M(+30.0%) | -$11.16 M(+6.8%) |
| Mar 2012 | - | -$2.31 M(-25.9%) | -$10.46 M(+16.0%) |
| Dec 2011 | -$9.02 M(-31.4%) | -$3.12 M(+13.7%) | -$9.02 M(+7.3%) |
| Sept 2011 | - | -$2.74 M(+19.4%) | -$8.40 M(-11.6%) |
| June 2011 | - | -$2.29 M(+164.9%) | -$9.50 M(+10.2%) |
| Mar 2011 | - | -$866.00 K(-65.4%) | -$8.62 M(-34.4%) |
| Dec 2010 | -$13.14 M(+83.0%) | -$2.50 M(-34.8%) | -$13.14 M(+56.0%) |
| Sept 2010 | - | -$3.84 M(+171.0%) | -$8.42 M(+20.0%) |
| June 2010 | - | -$1.42 M(-73.7%) | -$7.02 M(-25.9%) |
| Mar 2010 | - | -$5.38 M(-343.2%) | -$9.47 M(+31.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$7.18 M(-41.2%) | $2.21 M(-190.8%) | -$7.18 M(-41.3%) |
| Sept 2009 | - | -$2.44 M(-37.1%) | -$12.23 M(-7.4%) |
| June 2009 | - | -$3.87 M(+25.4%) | -$13.21 M(+8.8%) |
| Mar 2009 | - | -$3.09 M(+8.8%) | -$12.14 M(-0.6%) |
| Dec 2008 | -$12.22 M(-32.6%) | -$2.84 M(-16.9%) | -$12.22 M(-4.4%) |
| Sept 2008 | - | -$3.42 M(+21.9%) | -$12.78 M(-15.3%) |
| June 2008 | - | -$2.80 M(-11.5%) | -$15.08 M(-6.9%) |
| Mar 2008 | - | -$3.17 M(-6.8%) | -$16.20 M(-10.7%) |
| Dec 2007 | -$18.14 M(-6.5%) | -$3.40 M(-40.6%) | -$18.14 M(-6.2%) |
| Sept 2007 | - | -$5.72 M(+45.7%) | -$19.34 M(+11.0%) |
| June 2007 | - | -$3.92 M(-23.0%) | -$17.42 M(-6.2%) |
| Mar 2007 | - | -$5.10 M(+11.1%) | -$18.58 M(-4.2%) |
| Dec 2006 | -$19.40 M(+55.9%) | -$4.59 M(+20.6%) | -$19.40 M(+6.1%) |
| Sept 2006 | - | -$3.81 M(-25.1%) | -$18.29 M(+6.8%) |
| June 2006 | - | -$5.08 M(-14.2%) | -$17.12 M(+11.3%) |
| Mar 2006 | - | -$5.92 M(+70.2%) | -$15.39 M(+23.6%) |
| Dec 2005 | -$12.45 M(-26.3%) | -$3.48 M(+31.6%) | -$12.45 M(+156.6%) |
| Sept 2005 | - | -$2.64 M(-21.0%) | -$4.85 M(-47.4%) |
| June 2005 | - | -$3.35 M(+12.2%) | -$9.21 M(-22.1%) |
| Mar 2005 | - | -$2.98 M(-172.4%) | -$11.83 M(-30.0%) |
| Dec 2004 | -$16.89 M(+20.7%) | $4.12 M(-158.8%) | -$16.89 M(-30.4%) |
| Sept 2004 | - | -$7.01 M(+17.6%) | -$24.27 M(+7.0%) |
| June 2004 | - | -$5.96 M(-25.9%) | -$22.68 M(+11.1%) |
| Mar 2004 | - | -$8.04 M(+146.3%) | -$20.42 M(+45.9%) |
| Dec 2003 | -$13.99 M(+88.5%) | -$3.27 M(-39.8%) | -$13.99 M(+15.3%) |
| Sept 2003 | - | -$5.42 M(+47.0%) | -$12.14 M(+41.0%) |
| June 2003 | - | -$3.69 M(+128.1%) | -$8.61 M(+14.0%) |
| Mar 2003 | - | -$1.62 M(+14.6%) | -$7.55 M(+1.7%) |
| Dec 2002 | -$7.42 M(-18.3%) | -$1.41 M(-25.4%) | -$7.42 M(-8.7%) |
| Sept 2002 | - | -$1.89 M(-28.2%) | -$8.13 M(-3.0%) |
| June 2002 | - | -$2.63 M(+77.0%) | -$8.38 M(+3.6%) |
| Mar 2002 | - | -$1.49 M(-29.6%) | -$8.09 M(-10.9%) |
| Dec 2001 | -$9.08 M(+6.2%) | -$2.12 M(-1.4%) | -$9.08 M(-3.6%) |
| Sept 2001 | - | -$2.15 M(-8.5%) | -$9.42 M(+0.8%) |
| June 2001 | - | -$2.34 M(-5.5%) | -$9.34 M(+3.1%) |
| Mar 2001 | - | -$2.48 M(+1.0%) | -$9.06 M(+5.9%) |
| Dec 2000 | -$8.55 M(-30.5%) | -$2.45 M(+18.8%) | -$8.55 M(-22.9%) |
| Sept 2000 | - | -$2.07 M(+0.3%) | -$11.10 M(+1.5%) |
| June 2000 | - | -$2.06 M(+4.5%) | -$10.93 M(-4.7%) |
| Mar 2000 | - | -$1.97 M(-60.5%) | -$11.47 M(-7.5%) |
| Dec 1999 | -$12.30 M(+68.5%) | -$5.00 M(+163.1%) | -$12.40 M(+25.2%) |
| Sept 1999 | - | -$1.90 M(-26.9%) | -$9.90 M(+2.1%) |
| June 1999 | - | -$2.60 M(-10.3%) | -$9.70 M(+11.5%) |
| Mar 1999 | - | -$2.90 M(+16.0%) | -$8.70 M(+19.2%) |
| Dec 1998 | -$7.30 M(+19.7%) | -$2.50 M(+47.1%) | -$7.30 M(+21.7%) |
| Sept 1998 | - | -$1.70 M(+6.3%) | -$6.00 M(+3.4%) |
| June 1998 | - | -$1.60 M(+6.7%) | -$5.80 M(+9.4%) |
| Mar 1998 | - | -$1.50 M(+25.0%) | -$5.30 M(-13.1%) |
| Dec 1997 | -$6.10 M(+32.6%) | -$1.20 M(-20.0%) | -$6.10 M(-1.6%) |
| Sept 1997 | - | -$1.50 M(+36.4%) | -$6.20 M(0.0%) |
| June 1997 | - | -$1.10 M(-52.2%) | -$6.20 M(0.0%) |
| Mar 1997 | - | -$2.30 M(+76.9%) | -$6.20 M(+34.8%) |
| Dec 1996 | -$4.60 M(+155.6%) | -$1.30 M(-13.3%) | -$4.60 M(+27.8%) |
| Sept 1996 | - | -$1.50 M(+36.4%) | -$3.60 M(+38.5%) |
| June 1996 | - | -$1.10 M(+57.1%) | -$2.60 M(+30.0%) |
| Mar 1996 | - | -$700.00 K(+133.3%) | -$2.00 M(+11.1%) |
| Dec 1995 | -$1.80 M | -$300.00 K(-40.0%) | -$1.80 M(+20.0%) |
| Sept 1995 | - | -$500.00 K(0.0%) | -$1.50 M(+50.0%) |
| June 1995 | - | -$500.00 K(0.0%) | -$1.00 M(+100.0%) |
| Mar 1995 | - | -$500.00 K | -$500.00 K |
FAQ
- What is AIM ImmunoTech annual net profit?
- What is the all time high annual net income for AIM ImmunoTech?
- What is AIM ImmunoTech annual net income year-on-year change?
- What is AIM ImmunoTech quarterly net profit?
- What is the all time high quarterly net income for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly net income year-on-year change?
- What is AIM ImmunoTech TTM net profit?
- What is the all time high TTM net income for AIM ImmunoTech?
- What is AIM ImmunoTech TTM net income year-on-year change?
What is AIM ImmunoTech annual net profit?
The current annual net income of AIM is -$28.96 M
What is the all time high annual net income for AIM ImmunoTech?
AIM ImmunoTech all-time high annual net profit is -$1.80 M
What is AIM ImmunoTech annual net income year-on-year change?
Over the past year, AIM annual net profit has changed by -$9.52 M (-48.94%)
What is AIM ImmunoTech quarterly net profit?
The current quarterly net income of AIM is -$3.70 M
What is the all time high quarterly net income for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly net profit is $4.12 M
What is AIM ImmunoTech quarterly net income year-on-year change?
Over the past year, AIM quarterly net profit has changed by +$4.12 M (+52.66%)
What is AIM ImmunoTech TTM net profit?
The current TTM net income of AIM is -$23.93 M
What is the all time high TTM net income for AIM ImmunoTech?
AIM ImmunoTech all-time high TTM net profit is -$500.00 K
What is AIM ImmunoTech TTM net income year-on-year change?
Over the past year, AIM TTM net profit has changed by -$3.15 M (-15.18%)